site sponsored by
Tag Archive | "exelixis"
Tags: biogen, biotech, exelixis, helm, james-mullen, marketplace, novel-molecules, veteran-biotech
Sources: In surprise pick, Exelixis’ Scangos named CEO of Biogen Idec
Posted on 30 June 2010
Posted in Top NewsComments (0)
Tags: companies, compound, exelixis, experimental, having-the-drug, marked-the-end, more-completely, over-the-years, people, press-release, Print, structures, unenviable
Exelixis Gets a Compound Back
Posted on 23 June 2010
Posted in In the PipelineComments (0)
Tags: behind-as-pact, bristol-myers squibb, data-on-xl184, developer, drug, exelixis, partnership, rapidly-develop, review, told-the-wire, xl184
BMS writes off Exelixis’ lead cancer drug
Posted on 21 June 2010
Posted in Top NewsComments (0)
Tags: biotech ipo, bristol-myers squibb, data-on-xl184, developer, exelixis, nasdaq, partnership, rapidly-develop, review, shares-it-plans, told-the-wire, year
CRO braves the public market, files for $100M IPO
Posted on 21 June 2010
Posted in Top NewsComments (0)
Tags: approval, biotech, biotech ipo, bristol-myers squibb, data-on-xl184, exelixis, high-hopes, launch-its, multiple sclerosis, nasdaq, partnership, review, the-country, year
GW prices Sativex for MS pain
Posted on 21 June 2010
Posted in Top NewsComments (0)
Tags: business and markets, cboe, delayed-options, exelixis, orders-were, placed-before, something-odd, stock-today
Exelixis: Hmmmm.
Posted on 01 April 2010
Posted in In the PipelineComments (0)
Tags: advisory-committee, autoimmune-pact, biotech, exelixis, focus-on-three, francisco-based, its-preclinical, layoffs, million-through, morgan-stanley, potential, shares-advance, the-anticipated
Exelixis chops 270 jobs in restructuring
Posted on 09 March 2010
Posted in Top NewsComments (0)
Tags: all-departments, area-biotech, biotech, exelixis, from-the-sound, help-it-one, its-healthiest, scene-doesn, sound, the-numbers, their-work, work
Bad News at Exelixis
Posted on 08 March 2010
Posted in In the PipelineComments (0)
Tags: collaborations, efforts, european, exelixis, from-the-colon, its-preclinical, million-through, shares-advance, the-anticipated
ExonHit, bioMerieux nix colon cancer program
Posted on 08 March 2010
Posted in Top NewsComments (0)
Tags: collaborations, concern-warning, craig-philips, efforts, exelixis, from-the-colon, major-milestone, million-through, struggling, therapeutics, well-as-its
FDA OKs Cell Therapeutics’ manufacturing plant
Posted on 08 March 2010
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Athersys buoyed by upbeat PhI stem cell data
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
